Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christiane Villescaz"'
Autor:
David G. Parkes, Christiane Villescaz, Yan Wang, Lawrence J. D'souza, Krystyna Tatarkiewicz, Clara Polizzi, S. Janssen
Publikováno v:
Diabetes, Obesity & Metabolism
The combined glucose-lowering effect of exenatide and dapagliflozin has not yet been studied. We investigated this combination (single-dose or 4-week dosing) in diabetic ob/ob mice. Vehicle-corrected basal glucose showed greater reduction 1 h followi
Autor:
Clara Polizzi, David G. Parkes, Krystyna Tatarkiewicz, Emmanuel J. Sablan, Christiane Villescaz
Publikováno v:
American journal of physiology. Regulatory, integrative and comparative physiology. 306(7)
Glucagon-like peptide 1 receptors (GLP-1R) are expressed in multiple tissues and activation results in metabolic benefits including enhanced insulin secretion, slowed gastric emptying, suppressed food intake, and improved hepatic steatosis. Limited a
Autor:
Soumitra S. Ghosh, John Herich, Carrie Wittmer, Michelle D. Hendricks, Carolyn Lowe, Christiane Villescaz, Joseph S. Heilig, Carrie S. Dolman, Jason R. Clapper, Guibao Gu, Jonathan D. Roth, Jennifer Athanacio
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 305(7)
Shortcomings of previously reported preclinical models of nonalcoholic steatohepatitis (NASH) include inadequate methods used to induce disease and assess liver pathology. We have developed a dietary model of NASH displaying features observed clinica
Autor:
Denis Roy, Tina Whisenant, Krystyna Tatarkiewicz, Emmanuel J. Sablan, David G. Parkes, Pamela A. Smith, Donald E. Aumann, Lisa Adams, Christiane Villescaz, Clara Polizzi, Bronislava Gedulin, Melissa G. W. Lu, Diane M. Hargrove
The risk of developing pancreatitis is elevated in type 2 diabetes and obesity. Cases of pancreatitis have been reported in type 2 diabetes patients treated with GLP-1 (GLP-1R) receptor agonists. To examine whether the GLP-1R agonist exenatide potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4f671ccc5b4ac3cc01bf81eef4ab313
https://europepmc.org/articles/PMC3006257/
https://europepmc.org/articles/PMC3006257/